Company intelligence / Profile preview

AVVA RUS JSC

Moscow, Russian Federationavva-rus.ru ↗
Ownership
Private
Employees
~500
Development stage
Commercial
01

Overview

The company has conducted over 100 clinical trials and has a portfolio of more than 70 medical products

Therapeutic areas
Infectious Diseases
Modalities
Small moleculesbiological medicines (through related company AVVA Pharmaceuticals Ltd)
Industry
Biotech
02

Drug pipeline

2 assets

lignin hydrolytic

3

1 more asset in the full pipeline.

Beyond the preview

Go deeper on AVVA RUS JSC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AVVA RUS JSC.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call